MMS
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥501-1,000
📍Canton
MMS

About MMS

MMS holdings is a leading global data-focused CRO (Clinical research organization) & technology enabled clinical research and health data analytics solution company that supports the pharmaceutical, biotech, and medical device industries.

MMS news and updates

MMS Holdings Inc. partners with Thread

MMS Holdings Inc. (MMS) announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services.

Jan 1, 2022 | appliedclinicaltrialsonline.com

MMS Holdings Inc. partners with Medidata Solutions

MMS Holdings, a data-focused Contract Research Organization (CRO), is pleased to announce a strategic partnership with Medidata, a Dassault Systèmes company, to provide clients a full range of solutions for clinical data management (CDM) and decentralized clinical trial (DCT) technologies, including Medidata’s unified platform and Rave EDC (Electronic Data Capture).

Jan 1, 2022 | yahoo.com

MMS Holdings Inc. hires Kelly J. Hill as Chief Strategy Officer

MMS Holdings Inc. announced the appointment of Kelly J. Hill to Chief Strategy Officer.

Sep 15, 2022 | appliedclinicaltrialsonline.com

MMS Holdings Inc. signed new client MAPS Public Benefit Corporation on Jul 8th 22'.

MMS Holdings (MMS), an award-winning, data-focused contract research organization (CRO), announced today that it has been selected by MAPS Public Benefit Corporation (MAPS PBC) as its contract research organization for the development of a New Drug Application (NDA) for MDMA-assisted therapy for posttraumatic stress disorder (PTSD).

Jul 7, 2022 | michbio.org

MMS Holdings Inc. signed new client MAPS Public Benefit Corp on Aug 4th 22'.

MMS Holdings (MMS), an award-winning, data-focused contract research organization (CRO), announced today that it has been selected by MAPS Public Benefit Corporation (MAPS PBC) as its contract research organization for the development of a New Drug Application (NDA) for MDMA-assisted therapy for posttraumatic stress disorder (PTSD).

Aug 3, 2022 | michbio.org

MMS Holdings Inc. recognized as 2022 award winner of the Michigan Top Workplaces on Nov 21st 22'.

MMS Holdings, a data-focused contract research organization (CRO), has been named a 2022 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces.

Nov 3, 2022 | businesswire.com
See More